News Release

Zogenix to Present at the 8th Annual SVB Leerink Global Healthcare Conference


EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that Stephen J. Farr, President and CEO, will provide a corporate update at the 8th Annual SVB Leerink Global Healthcare Conference, being held February 27-March 1, 2019, in New York, NY. 

Zogenix Presentation Details

Date: Wednesday, February 27, 2019
Time: 9:00 AM Eastern Time / 6:00 AM Pacific Time
Location: New York, NY - Lotte New York Palace Hotel

The presentation will be webcast live and archived for 90 days on Zogenix's Investor Relations website at

About Zogenix
Zogenix is a global pharmaceutical company committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases. For more information, visit

Melinda Baker
Senior Director, Corporate Communications

Rachel Lipsitz
Public Relations, Syneos Health
+1 (858) 449 9575 |

Andrew McDonald
Founding Partner, LifeSci Advisors LLC
+1 (646) 597-6987 |



Source: Zogenix, Inc.